No fees unless we win.
Get a free consultation
The Boston Globe reported on September 10 that Biogen Idec Inc. and Irish drug maker Elan Pharmaceuticals Inc. are facing lawsuits after they allegedly failed to warn people about potentially dangerous side effects of the multiple sclerosis drug Tysabri.
Kimberley A. Yout, who was diagnosed with MS in 1997, said that she took Tysabri for six years and her “speech became slurred, her gait unsteady, and her future uncertain.”
“I was a very successful businesswoman,” Yout told the Globe “Today, I can’t even balance my checkbook, I can’t use an ATM, I can’t see out of one eye. I had to move back in with my mother. I’ve lost my independence. I’ve lost everything.”
According to the Globe, Yout’s lawsuit is one of more than at least a half-dozen pending in Massachusetts and federal courts in three other states. In the lawsuits, the plaintiffs are seeking more than $1 million in punitive damages.
The patients claim that after taking Tysabri, they developed progressive multifocal leukoencephalopathy (PML), an infection of the brain’s white matter that can cause death or severe disability.
Tysabri was approved by the FDA in 2004, but according to the Globe, its manufacturers pulled it off the market in 2005 after “several PML cases, two of which resulted in death.” It was brought back to the market in 2006, with several regulations, including a risk management program, training doctors prescribing it to monitor patients monthly.
The Globe reported that Tysabri generated profits of $1.6 billion in 2012, and is used by about 118,000 patients globally. According to the paper, there were 395 confirmed cases of Tysabri-associated PML, including 92 deaths, as of August.
Zoll, Kranz & Borgess, LLC (“ZKB”) specializes in assisting individuals injured or killed from dangerous, defective or contaminated medical drugs and devices. For more information, contact our pharmaceutical drug and device litigation attorneys by calling toll-free (888)841-9623.
Zoll, Kranz & Borgess, LLC – Medical Drug and Device Attorneys
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
